Project Grant R90HD118650
Award Date
9/1/24
Completion Date
6/30/29
Dollars Obligated
$703K
Funding Federal Agency
National Institute of Neurological Disorders and Stroke
Awarding Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Palo Alto, CA 94304, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $730,668 to Stanford University over a 5-year period starting September 1, 2024. The funding will support an interdisciplinary postdoctoral training program in clinical pain research, with a focus on maternal and childhood pain. The program aims to train the next generation of diverse scientific leaders in this field by providing mentorship,...
This $242,061 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) establishes an interdisciplinary clinical pain research training program at Mass General Brigham (MGB) in Boston. The program will support 8-12 postdoctoral fellows over 5 years, providing protected research time and dedicated training to expand the pool of early-career investigators capable of launching successful clinical...
This federal Project Grant award in the amount of $351,097 was provided by the National Institute of Neurological Disorders and Stroke (NINDS), which is part of the National Institutes of Health (NIH). The grant was awarded under the NIH's Drug Use and Addiction Research Programs (CFDA 93.279) to establish a rigorous and supportive interdisciplinary training program in clinical pain research at Mass General Brigham (MGB) in Boston. The program will support a diverse pool of 8 postdoctoral...
The National Institute on Drug Abuse (NIDA) awarded a $515,088 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Washington University in St. Louis. The grant, titled "Promoting Excellence through Pain and Addiction Research Enhancement (PREPARE)", aims to recruit and train 5 postdoctoral fellows (4 T90, 1 R90) to conduct mechanistically-based clinical research on the intersection of chronic pain and substance use disorders (SUD). The program will...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $290,312 to The Washington University in St. Louis to develop a postdoctoral training program called "Promoting Excellence through Pain and Addiction Research Enhancement (PREPARE)". The PREPARE program aims to recruit and train early career investigators to conduct clinical research on the intersection of...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $118,457 to The Trustees of the University of Pennsylvania to conduct research aimed at harnessing the genetics of chronic pain to inform the development of non-addictive analgesic medications. The 4-year project, starting on April 15, 2025, will characterize the genetic architecture underlying chronic pain liability and addiction, estimate...
The University of Florida was awarded a $362,689 Project Grant by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award titled "University of Florida Partnerships Across Interdisciplinary Networks: Training through Engineering, Epidemiology & Addiction Medicine (UF PAIN TEAM)" will establish an interdisciplinary postdoctoral training program to develop the next generation of independent...
The University of Utah received a $698,670 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) to implement the University of Utah Program to Provide Pain Research Knowledge (UP3RK). The UP3RK program aims to train an interdisciplinary group of post-graduate scholars in clinical pain research, with a focus on non-pharmacological pain treatments, interventions for pain and co-morbidities,...
This $2,249,392 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research to validate senescent cells as a target for the treatment of chronic pain in aging. The project aims to rigorously characterize the role of senescent neurons and their senescence-associated secretory phenotype (SASP) in driving dorsal root ganglion hyperexcitability and persistent pain following...
The National Institute on Drug Abuse (NIDA) awarded a $154,568 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Washington University in St. Louis. The grant, titled "Investigating the Role of Dorsal Raphe Nucleus Enkephalin Neurons in Motivational and Affective Behaviors During Chronic Pain", aims to determine the contribution of endogenous opioids in the dorsal raphe nucleus to motivational and affective dysregulation during chronic pain. The...